Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.
Hürlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, Béchir M, Spieker LE, Neidhart M, Michel BA, Gay RE, Lüscher TF, Gay S, Ruschitzka F.
Hürlimann D, et al. Among authors: distler o.
Circulation. 2002 Oct 22;106(17):2184-7. doi: 10.1161/01.cir.0000037521.71373.44.
Circulation. 2002.
PMID: 12390945
Clinical Trial.